Yahoo Finance Acorda Therapeutics (ACOR) in Focus: Stock Moves 5.7% Higher
Acorda Therapeutics, Inc. ACOR was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.68 –$2.75 in the past one-month time frame, witnessed a sharp increase yesterday.
Over the last 30 days, the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Acorda Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Acorda Therapeutics, Inc. Price
Acorda Therapeutics, Inc. price | Acorda Therapeutics, Inc. Quote
A better-ranked stock in the Medical - Biomedical and Genetics industry is Amarin Corporation PLC AMRN, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ACOR going up? Or down? Predict to see what others think: Up or Down
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Acorda Therapeutics, Inc. (ACOR) : Free Stock Analysis Report
Amarin Corporation PLC (AMRN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
